{{Rsnum
|rsid=303386
|Gene=RP5-896L10.1
|Chromosome=1
|position=99123823
|Orientation=plus
|GMAF=0.3916
|Gene_s=RP5-896L10.1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 34.5 | 58.4
| HCB | 26.1 | 44.0 | 29.9
| JPT | 28.3 | 44.2 | 27.4
| YRI | 22.0 | 54.6 | 23.4
| ASW | 8.9 | 44.6 | 46.4
| CHB | 26.1 | 44.0 | 29.9
| CHD | 27.9 | 45.2 | 26.9
| GIH | 1.0 | 35.6 | 63.4
| LWK | 19.3 | 53.2 | 27.5
| MEX | 12.5 | 44.6 | 42.9
| MKK | 11.0 | 61.3 | 27.7
| TSI | 4.0 | 39.0 | 57.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=4E-6
  |OR=1.77
  |ORtxt=[1.256-2.483]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}